Twitter | Search | |
Search Refresh
C&EN 3m
Just how valuable might messenger RNA-based drugs be? That question is about to be put to the test. Moderna Therapeutics has filed for a record IPO. At $500 million, if successful, it will be the largest initial public offering in history.
Reply Retweet Like
Key Tech, Inc. 8m
Say hello to Sam Gulloti at the Key Tech Booth at the MEDTECH 2018: Connect New York; Tech Showcase 11/13-14
Reply Retweet Like
SynBioBeta Nov 11
How to Engineer Biology - Billion-dollar bridges rarely fail—whereas billion-dollar drug failures are routine
Reply Retweet Like
Microbiome Insights 1h
Microbiome Insights CEO Malcolm Kendall moderated a panel on venture capital in healthcare at last week's UNC Business School Healthcare Conference -- seen here with panelists Art Pappas, Christy Shaffer, and Paul Boyer.
Reply Retweet Like
Max 2h
A Pathway for Pioneers: Merck’s Biotechnology Partnership Program
Reply Retweet Like
Sentiment Stocks Nov 10
Article on estimates an IMPRESSIVE 32% OS for -L in P3 treatment arm, and 19% OS for control live to ≥ 36 months - an approximate 68% improvement over control.
Reply Retweet Like
Rumors, Murmurs & Buzz 22h
Dot The I's And Cross The T's_Pfizer CEO Ian Read And Amarin CEO John Thero Meeting In Dublin As New Positive Results Demonstrate Vascepa Effectiveness In 26% Reduction For Secondary Cardiovascular Death, Heart Attacks and Strokes
Reply Retweet Like
CSL 5m
Reply Retweet Like
NON_FICTION_1 8h
today .. hold on tight
Reply Retweet Like
Max 1h
Top Ten Biotechs in Scotland to Watch Out For
Reply Retweet Like
Baiju R. Shah 2h
"The 1st misconception is that impact can't be measured. The 2nd is that any sort of business or decision making that is based on impact rules will ultimately lead to lower returns." Using to fund is a great way to do well by doing good.
Reply Retweet Like
Katie Saund 20h
I've been reading recently about & . 1. "Genentech" by S. S. Hughes | 2. "Gene Jockeys" by N. Rasmussen | 3. Today finished "Venture Deals" by & . Do you have any biotech/startup book recommendations?
Reply Retweet Like
Max Nov 7
Do You Have The Koalifications?
Reply Retweet Like
Max Nov 7
Biohacking: Democratization of Science or Just a Quirky Hobby?
Reply Retweet Like
Howard Regay 17m
Reply Retweet Like
HudsonAlpha 1h
Excited for ! Attendees: stop by the work lounge to mix & mingle w/ investors, companies & innovators. Be sure to chat w/ ’s about bringing your company to
Reply Retweet Like
Zack Capp 2h
ContraFect to Report Phase 2 Data Before the End of 2018
Reply Retweet Like
Ava Chiao 2m
Duane from for providing an price for the -80•C freezer to . We are expanding our program
Reply Retweet Like
robertVERITAS Nov 10
Myasthenia Gravis (MG) - here you'll find info on the autoimmune disorder & the most common drugs prescribed. None of which cure MG. That's why brings hope. They are developing TOL2, which has shown extraordinary preclinical results.
Reply Retweet Like
Clustermarket 10h
We are present at over the next couple of days. Excited to hear from the leaders in pharma about what tomorrow looks like
Reply Retweet Like